AstraZeneca Hits U.K. Antitrust Review with $39B Alexion Buy After U.S. FTC Clearance

November 19, 2025

Informa 34th Annual Advanced EU Brussels Conference

On November 19, Axinn partner Jimmy Attridge will speak on the "Competition Policy in the New Geopolitical Landscape" panel at Informa's Advanced EU Brussels Conference, being held November 18-19.

Speaking Engagement

Antitrust

November 19, 2025

Kisaco Research Pharma and Biotech Patent Litigation Summit 2025

On November 19, Axinn partner Matthew Murphy will speak on the "Understanding IP Exclusivity Rights Considering the Latest Antitrust Landscape" panel at Kisaco Research's Pharma & Biotech Patent Litigation Summit, being held November 18-19 in Philadelphia.

Speaking Engagement

Intellectual Property

November 18, 2025

GCR Live: Women in Antitrust 2025

On November 18, Axinn partner Lisl Dunlop will speak on "The Next Four Years: Merger Control Following U.S. Leadership Changes" at Global Competition Review's Women in Antitrust conference in Washington, DC.

Speaking Engagement

Antitrust

November 18, 2025

Global Legal Group Global Class Actions Symposium 2025

On November 18, Axinn partner Craig Reiser will chair the "Class Actions in the USA" panel at Global Legal Group's Global Class Actions Symposium, being held November 18-19 in London.

Speaking Engagement

Litigation & Trials

November 12, 2025

ITCTLA Mock Hearing Program 2025

Axinn partners Brian Johnson and Joseph Micallef have been selected to participate as coaches for the International Trade Commission Trial Lawyers Association’s Mock Hearing Program in Washington, DC on November 12. Associates Raymond Braha and Cassie Goodnight have been selected to participate as NEXT Advocates.

Speaking Engagement

Intellectual Property

November 10, 2025

ALM General Counsel Conference East 2025

On November 10, Axinn partner Bradley Justus will speak on the "Balancing Cost & Counsel: Optimizing Legal Budgets" roundtable discussion at ALM's General Counsel Conference East, being held November 10-11 in New York.

Speaking Engagement

Antitrust

November 10, 2025

Axinn Recognized in Thirteen Categories of 2026 “Best Law Firms” Report

Best Lawyers® has released its 2026 Best Law Firms® rankings, and Axinn is proud to announce that the firm has been recognized in thirteen categories across national and regional tiers.

Awards & Recognitions

Antitrust

November 10, 2025

Mastering Multi-Jurisdictional Mergers: Strategies for Navigating Complex Global Antitrust Reviews

Axinn partners John Harkrider and Michael O’Mara co-authored the “Mastering Multi-Jurisdictional Mergers: Strategies for Navigating Complex Global Antitrust Reviews” chapter in the sixth edition of the Global Competition Review publication, Merger Remedies Guide.

Byline Articles

Antitrust

November 10, 2025

The Government Shutdown’s Impact on Antitrust

On October 1, 2025, the federal government shut down, causing non-essential government agencies to close temporarily due to a lapse in...

Axinn Viewpoints

Antitrust

November 6, 2025

NAPABA Convention 2025

Axinn is pleased to announce its sponsorship of the National Asian Pacific American Bar Association’s Annual Convention, being held November 6-8 in Denver.

Sponsorship

Antitrust

November 3, 2025

IBA Annual Conference 2025

On November 3, Axinn antitrust practice chair Mike Keeley will speak on the "Competition Law Compliance in the World of Shifting Antitrust Enforcement and High Tech" panel at the International Bar Association's Annual Conference, being held November 2-7 in Toronto.

Speaking Engagement

Antitrust

October 31, 2025

Streamlining The Studies: New FDA Guidance Aims to Speed Up Biosimilar Development

On Wednesday, the FDA issued a new draft guidance proposing to reduce the need for sponsors to conduct a comparative efficacy study (CES)...

Axinn Viewpoints

Intellectual Property

AstraZeneca Hits U.K. Antitrust Review with $39B Alexion Buy After U.S. FTC Clearance

Related People

Related Services

Featured Insights

Featured Insights